Search hospitals > Texas > San Antonio
University of Texas Health Science Center at San Antonio
Claim this profileSan Antonio, Texas 78229
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Brain Tumor
1130 reported clinical trials
77 medical researchers
Summary
University of Texas Health Science Center at San Antonio is a medical facility located in San Antonio, Texas. This center is recognized for care of Cancer, Tumors, Leukemia, Lymphoma, Brain Tumor and other specialties. University of Texas Health Science Center at San Antonio is involved with conducting 1,130 clinical trials across 1,103 conditions. There are 77 research doctors associated with this hospital, such as Anne-Marie R. Langevin, John Browning, Virginia G. Kaklamani, and Michael A. Liss.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Anne-Marie R. LangevinUniversity of Texas Health Science Center at San Antonio7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
65 reported clinical trials
116 drugs studied
John BrowningTexas Dermatology and Laser Specialists6 years of reported clinical research
Studies Atopic Dermatitis
Studies Eczema
12 reported clinical trials
17 drugs studied
Virginia G. KaklamaniUniversity of Texas Health Science Center at San Antonio7 years of reported clinical research
Studies Breast Cancer
Studies Cancer
11 reported clinical trials
44 drugs studied
Michael A. LissUniversity of Texas Health Science Center at San Antonio3 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
13 reported clinical trials
31 drugs studied
Clinical Trials running at University of Texas Health Science Center at San Antonio
Breast Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Cancer
Brain Tumor
Tumors
Lung Cancer
Osteosarcoma
Gallbladder Cancer
Parkinson's Disease
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Texas Health Science Center at San Antonio?
University of Texas Health Science Center at San Antonio is a medical facility located in San Antonio, Texas. This center is recognized for care of Cancer, Tumors, Leukemia, Lymphoma, Brain Tumor and other specialties. University of Texas Health Science Center at San Antonio is involved with conducting 1,130 clinical trials across 1,103 conditions. There are 77 research doctors associated with this hospital, such as Anne-Marie R. Langevin, John Browning, Virginia G. Kaklamani, and Michael A. Liss.
Where is University of Texas Health Science Center at San Antonio located?
The University of Texas Health Science Center at San Antonio hospital is situated at 7703 Floyd Curl Drive in the South Texas Medical Center, accessible via Interstates 10 and 410. For those coming from Interstate 10, exit at Medical Drive, head west, and then turn left onto Floyd Curl Drive to find the main entrance near Medical Drive.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Texas Health Science Center at San Antonio:
- **CareLink**: For enrollment and renewal options, call 210-358-3350 or visit their website.
- **Insurance Inquiries**: Contact Academic Health Plans at (855) 247-2273 or visit help.ahpcare.com.
- **General Financial Aid**: Reach out to UT Health San Antonio Veteran Services & Financial Aid at 7703 Floyd Curl MSC 7708, San Antonio, Texas, 78229, or call (210) 567-2696.
What insurance does University of Texas Health Science Center at San Antonio accept?
**University of Texas Health Science Center at San Antonio Insurance Information:**
- **Students:** The University of Texas System Student Health Insurance Plan is accepted, utilizing the BlueChoice PPO Network. This plan covers injury and sickness, with options for graduating students to extend coverage.
- **Employees:** The UT SELECT Medical Plan, administered by Blue Cross and Blue Shield of Texas, provides medical and prescription coverage, including low copayments for in-network services, a deductible, and coverage for lab and x-ray services associated with office visits, preventive care, and telemedicine.
- **UT Physicians:** Accepts various insurance plans including Aetna, Blue Cross Blue Shield Texas, Cigna, Humana, and UnitedHealthcare. It's advised to confirm with your plan about network provider availability.
What awards or recognition has University of Texas Health Science Center at San Antonio received?
UT Health San Antonio ranks among the top 5 in Texas and top 25 nationally for NIH funding, showcasing its research excellence. The center has launched 5 start-up companies and generated over $889,000 from intellectual property licensing in FY20. It boasts prestigious researchers, including 8 members of the National Academy of Medicine and 15 members of the American Society of Clinical Investigation, with a research focus on cancer therapy, longevity and aging studies, and community-based health promotion in women and children.